ASX Share rice
Sat 15 Aug 2020 - 09:13:pm (Sydney)

ACR Share Price

ACRUX LIMITEDACRPharmaceuticals, Biotechnology & Life Sciences

ACR Company Information

Name:

Acrux Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

103-113 Stanley Street West Melbourne Australia 3003

Phone:

61 3 8379 0100

CEO, MD & Exec. Director:

Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus

CFO & Company Sec.:

Ms. Deborah Ambrosini

Company Overview:

Acrux Limited, together with its subsidiaries, develops and commercializes specialty and generic topical pharmaceuticals in Australia, Switzerland, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.

ACR Share Price Information

Shares Issued:

168.47M

Market Capitalisation:

$28.64M

Revenue (TTM):

$3.39M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.05

Operating Margin (TTM):

$-3.11

Return On Assets (TTM):

$-0.27

Return On Equity (TTM):

$-0.53

Quarterly Revenue Growth (YOY):

-0.813

Gross Profit(TTM):

$163K

Diluted Earnings Per Share (TTM):

$-0.067

ACR CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-380,000

Change To Liabilities:

$-96,000

Total Cashflow From Investing Activities:

$-380,000

Net Income:

$-8,325,000

Total Cash From Operating Activities:

$-9,938,000

Depreciation:

$319K

Change To Account Receivables:

$-2,040,000

Capital Expenditures:

$380K

ACR Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-8,335,000

Net Income:

$-8,325,000

Gross Profit:

$631K

Operating Income:

$-12,990,000

Other Operating Expenses:

$1.11M

Income Tax Expense:

$-10,000

Total Revenue:

$631K

Total Operating Expenses:

$13.62M

Cost Of Revenue:

$5.12M

ACR Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$696K

Total Liabilities:

$2.50M

Total Stockholder Equity:

$21.94M

Other Current Liabilities:

$0.97M

Total Assets:

$24.43M

Common Stock:

$95.88M

Other Current Assets:

$487K

Retained Earnings:

$-74,582,000

Other Liabilities:

$81K

Other Assets:

$2.59M

Cash:

$18.15M

Total Current Liabilities:

$2.42M

Property - Plant & Equipment:

$0.91M

Net Tangible Assets:

$21.94M

Total Current Assets:

$20.94M

Net Receivables:

$198K

Short-Term Investments:

$3.49M

Accounts Payable:

$0.90M

Non Currrent Assets (Other):

$3.49M

Short-Term Investments:

$3.49

Non Current Liabilities Total:

$81K

ACR Share Price History

ACR News

13 Mar, 2020
Michael Kotsanis has been the CEO of Acrux Limited (ASX:ACR) since 2014. First, this article will compare CEO...
31 Dec, 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
30 Oct, 2019
We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...
16 Sep, 2019
Michael Kotsanis became the CEO of Acrux Limited (ASX:ACR) in 2014. This analysis aims first to contrast CEO...

ACR Dividend Payments

EX-Date Dividend Amount
2012-09-04$0.0800
2013-09-03$0.0800
2014-09-04$0.0800
2015-08-18$0.0600

ACR Dividends (last 4 Years)